These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8198540)

  • 1. Glucose oxidation and low-density lipoprotein-induced macrophage ceroid accumulation: possible implications for diabetic atherosclerosis.
    Hunt JV; Bottoms MA; Clare K; Skamarauskas JT; Mitchinson MJ
    Biochem J; 1994 May; 300 ( Pt 1)(Pt 1):243-9. PubMed ID: 8198540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidized low density lipoprotein induces ceroid accumulation by murine peritoneal macrophages in vitro.
    Ball RY; Bindman JP; Carpenter KL; Mitchinson MJ
    Atherosclerosis; 1986 May; 60(2):173-81. PubMed ID: 2424465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ascorbic acid oxidation: a potential cause of the elevated severity of atherosclerosis in diabetes mellitus?
    Hunt JV; Bottoms MA; Mitchinson MJ
    FEBS Lett; 1992 Oct; 311(2):161-4. PubMed ID: 1397304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differing effects of probucol and vitamin E on the oxidation of lipoproteins, ceroid accumulation and protein uptake by macrophages.
    Hunt JV; Bottoms MA; Taylor SE; Lyell V; Mitchinson MJ
    Free Radic Res; 1994 Mar; 20(3):189-201. PubMed ID: 8019642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose.
    Hunt JV; Smith CC; Wolff SP
    Diabetes; 1990 Nov; 39(11):1420-4. PubMed ID: 2227114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway.
    Kawamura M; Heinecke JW; Chait A
    J Clin Invest; 1994 Aug; 94(2):771-8. PubMed ID: 8040332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceroid, macrophages and atherosclerosis.
    Mitchinson MJ; Ball RY; Carpenter KH; Enright JH; Brabbs CE
    Biochem Soc Trans; 1990 Dec; 18(6):1066-9. PubMed ID: 2088808
    [No Abstract]   [Full Text] [Related]  

  • 8. Why is glycated LDL more sensitive to oxidation than native LDL? A comparative study.
    Sobal G; Menzel J; Sinzinger H
    Prostaglandins Leukot Essent Fatty Acids; 2000 Oct; 63(4):177-86. PubMed ID: 11049692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycation and oxidation: a role in the pathogenesis of atherosclerosis.
    Lyons TJ
    Am J Cardiol; 1993 Feb; 71(6):26B-31B. PubMed ID: 8434558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid oxidation, lipoprotein cell-association and ceroid accumulation in P388D1 macrophage-like cells.
    Marchant CE; Bottoms MA; Law N; Mitchinson MJ; Hunt JV
    Biochim Biophys Acta; 1994 Dec; 1215(3):267-74. PubMed ID: 7811710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycation and glycoxidation of low-density lipoproteins by glucose and low-molecular mass aldehydes. Formation of modified and oxidized particles.
    Knott HM; Brown BE; Davies MJ; Dean RT
    Eur J Biochem; 2003 Sep; 270(17):3572-82. PubMed ID: 12919321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants.
    Aviram M
    Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):599-608. PubMed ID: 8877334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygen radicals and atherosclerosis.
    Carpenter KL; Brabbs CE; Mitchinson MJ
    Klin Wochenschr; 1991 Dec; 69(21-23):1039-45. PubMed ID: 1798277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The salicylate metabolite gentisic acid, but not the parent drug, inhibits glucose autoxidation-mediated atherogenic modification of low density lipoprotein.
    Exner M; Hermann M; Hofbauer R; Kapiotis S; Speiser W; Held I; Seelos C; Gmeiner BM
    FEBS Lett; 2000 Mar; 470(1):47-50. PubMed ID: 10722843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-enzymatic glycosylation of lipoproteins in the pathogenesis of atherosclerosis in diabetics].
    Calvo C
    Rev Med Chil; 1997 Apr; 125(4):460-5. PubMed ID: 9460289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized LDL ceroid, and prostaglandin metabolism in human atherosclerosis.
    Armstrong DA
    Med Hypotheses; 1992 Jul; 38(3):244-8. PubMed ID: 1513282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid peroxidation and ceroid accumulation in macrophages cultured with oxidized low density lipoprotein.
    Shimasaki H; Maeba R; Tachibana R; Ueta N
    Gerontology; 1995; 41 Suppl 2():39-51. PubMed ID: 8821320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative reactivity of the myeloperoxidase-derived oxidants HOCl and HOSCN with low-density lipoprotein (LDL): Implications for foam cell formation in atherosclerosis.
    Ismael FO; Proudfoot JM; Brown BE; van Reyk DM; Croft KD; Davies MJ; Hawkins CL
    Arch Biochem Biophys; 2015 May; 573():40-51. PubMed ID: 25795019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of glucose-mediated LDL oxidation on the P388D1 macrophage-like cell line.
    Millican SA; Bagga M; Eddy R; Mitchinson MJ; Hunt JV
    Atherosclerosis; 1997 Feb; 129(1):17-25. PubMed ID: 9069512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis.
    Hodgkinson CP; Laxton RC; Patel K; Ye S
    Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2275-81. PubMed ID: 18818414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.